United States · Who invested in Refuge Biotechnologies?
Refuge Biotechnologies's investors include HSG, DHVC, 3E Bioventures, BioVenture and ShangBay Capital, and 5 more on record.
United States · Series B startup
Who invested in Refuge Biotechnologies
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $25MMay 2018
- Investors
- 10
The rounds
- May 2018Series B$25M
HSG
DHVC
3E Bioventures- BioVenture
ShangBay Capital
Sangel Capital- Wuxi Capital
- 3SBio
- Ocean Pine Healthcare
- Sequoia China/ Danhua
Reported by FinSMEsSEC filing: $10.0M sold, first sale May 2018
Founders and team
From the SEC filings it signed: 1 on the team.
- Bing C. WangExecutive Officer, Directori
On the board, as filediCuiping C. GuDavid C. ParkinsonKaren C. LiuScott C. SmithZhenping C. Zhu
Everyone who backed them
BioVentureVC firm1round
Wuxi CapitalPrivate equity1round
3SBiono record of our own yet1round
Ocean Pine Healthcareno record of our own yet1round
Sequoia China/ Danhuano record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Refuge Biotechnologies
How much has Refuge Biotechnologies raised?
Refuge Biotechnologies has raised $25M across 1 round since 2018.
When did Refuge Biotechnologies last raise?
Refuge Biotechnologies's most recent round was a Series B of $25M in May 2018.
What was Refuge Biotechnologies's biggest round?
Its most recent round, $25M in May 2018, is also its largest on record.
Who backed Refuge Biotechnologies first?
Refuge Biotechnologies's first round on record, in May 2018, was backed by HSG, DHVC and 3E Bioventures and 7 others.
What stage is Refuge Biotechnologies at?
Refuge Biotechnologies's latest named round is a Series B, in May 2018.
Where is Refuge Biotechnologies based?
Refuge Biotechnologies is based in the United States.
Companies like Refuge Biotechnologies
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.